Abstract:Background Ocular graft-versus-host disease (oGVHD) is one of the complications after allogeneic hematopoietic stem cell transplantation (HSCT), which impairs the quality of life and may indicate poor prognosis. In this retrospective study, the aim was to investigate the characteristics of ocular surface after HSCT, and analyze the risk factors related to the severity of ocular surface lesions. Methods 248 post-HSCT patients were enrolled in this retrospective study. Subjects were divided into no lesion group, mild lesion group and severe lesion group, according to the severity of ocular surface lesions. The correlations between grades of ocular surface lesions and gender, age, primary disease, donor source, human leukocyte antigen (HLA) type, kinship, donor-recipient relationship, blood type, source of stem cell and systemic GVHD were analyzed. Results The median scores of corneal epitheliopathy, lid margin lesions and meibomian gland loss were 3, 6 and 2 points, respectively. The grade of corneal epitheliopathy was related to donor source (P<0.001), kinship (P=0.033), HLA-matching (P<0.001), and systemic GVHD (P=0.007), especially oral GVHD (P<0.001) and liver GVHD (P=0.002). The grade of lid margin lesions was related to donor source (P=0.019), HLA-matching (P=0.006), and systemic GVHD (P=0.013), especially skin GVHD (P=0.019) and oral GVHD (P=0.019). The grade of meibomian gland loss was related to age (P=0.035) and gastrointestinal GVHD (P=0.007). The grade of corneal epitheliopathy after HSCT was related to the lid margin lesion score (P<0.001). Conclusions The occurrence and development of ocular GVHD are mostly accompanied by the history of systemic GVHD. While in few cases, ocular surface lesions related to GVHD can be observed prior to the rejection of other tissues and organs. Severe corneal epitheliopathy occurs in patients with severe lid margin lesions in ocular GVHD. The lesions of corneal epithelium and lid margin are milder in HLA partially matching transplantation.

Common and specific dimensions of self-reported anxiety and depression: implications for the cognitive and tripartite models.

The ocular graft-versus-host disease: the path from current knowledge to future managements

Ocular graft-versus-host disease (oGVHD): From A to Z

Molecular characterization of human leukemia: Genotyping of lymphoid malignancies with immuno-globulin and T-cell receptor gene probes and application of a brc-specific probe in the classification of chronic myelogeneous and acute lymphoblastic leukemias

Diagnosis and treatment of ocular graft-versus-host disease

A brief account on ocular graft versus host disease

“Window of Opportunity” in Ocular Graft-Versus-Host Disease Treatment: Results of a Longitudinal Study and Case Reports

Ocular screening for chronic graft-versus-host disease in patients with allogeneic hematopoietic stem cell transplant

Predictive current control for a VSI with reduced common mode voltage operating at fixed switching frequency

Advances in the ocular complications after hematopoietic stem cell transplantation

Prevalence and risk factors associated with development of ocular GVHD defined by NIH consensus criteria

Lessons Learned From Ocular Graft versus Host Disease: An Ocular Surface Inflammatory Disease of Known Time of Onset

Analyses and Correlation of Pathologic and Ocular Cutaneous Changes in Murine Graft versus Host Disease

Correlative factors of ocular surface lesions after allogeneic hematopoietic stem cell transplantation: A retrospective study

Molecular Biomarkers in Ocular Graft-versus-Host Disease: A Systematic Review

Manifestation of Clinical Categories of Ocular Graft-versus-Host Disease.

Ocular surface indicators and biomarkers in chronic ocular graft-versus-host disease: a prospective cohort study

Chronic graft-versus-host disease after allogeneic stem cell transplantation: challenges in prevention, science, and supportive care

Novel approaches for preventing acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

MR Angiography Follow-Up of Aneurysms Treated with Coils: Is There a Need for the Use of Gadolinium?

Posterior segment complications and the risk factors after allogeneic hematopoietic stem cell transplantation